NovellusDx: Funding, Investors & Team (Sep 2026)
Novellusdx develops tumor specific driver mutations.
NovellusDx has raised $57.0M across 1 funding round on record, the most recent an undisclosed round of $57.0M announced in Sep 2020.
That round is above the $13M median round size for Israel companies tracked on FundedIQ over the last two years.
NovellusDx Company Profile and Key Stats
Latest funding round on record: Sep 2020.
NovellusDx Funding Rounds
NovellusDx Founders and Leadership Team
Contact details for the NovellusDx team: 1 of 1 has an email address on file.
Start 14-day free trial →NovellusDx Funding in Context
NovellusDx's latest round of $57.0M is above the median round in Israel. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like NovellusDx in Biotechnology and Jerusalem
Companies Similar to NovellusDx
Hopstem is a pharmaceutical company engaged in human iPSCs/ESCs neural differentiation, cell banking, and…
Immune Regulation is a clinical-stage biotech company pioneering new technologies for resetting the immune…
Swish Basket is an AI-powered basketball training and gaming platform that provides personalized coaching…
Remepy is biotechnology research pioneering hybrid drugs.
Corma develops foundation models and artificial intelligence systems for defensive cybersecurity.
Faye provides whole-trip travel coverage and care that brings out the best in each journey with…
By utilising runtime application context and leveraging the most exact open source security solution…
QuantHealth is an organization that produces software using artificial intelligence technology for drug…
Above Security provides cybersecurity services focused on threat detection, risk management, and compliance…
Zenity is a leading company that assists businesses in securing and managing AI Agents and Apps. The era of…
Xsight Labs is an Israeli company that develops technology for accelerating the next-generation, cloud-based,…
Cytactic is a company that specializes in cyber crisis management, offering services such as advisory,…
NovellusDx Funding FAQs
What does NovellusDx do?
Novellusdx develops tumor specific driver mutations.
How much funding has NovellusDx raised?
NovellusDx has raised $57.0M across 1 round on record. The most recent is an undisclosed round of $57.0M announced in Sep 2020.
When did NovellusDx last raise funding?
NovellusDx's most recent funding round on record is an undisclosed round of $57.0M, announced in Sep 2020.
Who is the CEO of NovellusDx?
Haim Gil is listed as CEO at NovellusDx.
Where is NovellusDx headquartered?
NovellusDx is based in Jerusalem, N/A, Israel.
How many employees does NovellusDx have?
NovellusDx is in the 51-100 employee band.
About FundedIQ's NovellusDx Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for NovellusDx is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.